315.5: Overexpression of CTRP9 Mediated by AAV Prevents Graft Loss after Islet Transplantation
Xiaofeng Gu,Xiaoqian Ma,Wei Wang
DOI: https://doi.org/10.1097/01.tp.0000994372.76123.0a
2023-01-01
Transplantation
Abstract:Introduction: As a promising clinic therapy of type 1 diabetes, islet transplantation was limited by graft failure. The primary nonimmune obstructive factor was reactive oxygen species (ROS), which causing by intraperitoneal hypoxia environment. The generation of ROS leads sets of downstream reactions, such as Damage-associated molecular patterns (DAMPs) release, oxidative stress (OS), mitochondrial dysfunction, endoplasmic reticulum stress (ERS), inflammation, even apoptosis. C1q/tumor necrosis factor related protein 9 (CTRP9) is a recently discovered adipokine, which has diverse physiological functions, including mitigate OS, alleviate inflammation and suppress apoptosis in various organs. In this study, an islet cells overexpressing CTRP9 gene were established, and the engineering islets are aiming to prolong the graft survival. Methods: Mouse islets were isolated by Liberase RT and the adeno-associated virus (AAV) mediated murine CTRP9 gene was transferred to the syngeneic suboptimal islets. The expression of CTRP9 at mRNA and protein level in engineering islets were measured by RT-qPCR and western blot (WB). In vitro, the engineering islets were incubated at hypoxia environment (1% O2) for 72 hours. The ERS markers, mitochondrial function, anti-oxidative enzymes, ROS generation, and the islets survival rate were detected. Then 200 engineering islets were transplanted to each diabetic mouse under the left kidney capsule, and the blood-glucose level were detected every other day. Results: The CTRP9 mRNA and protein level of the engineering islet were significantly higher than control islets. After 72h hypoxia treatment, the overexpression of CTRP9 significantly decreased the hypoxia-induced ERS markers (GRP78, CHOP, IRE1α), and the ROS generation (ROS, NOS, NO). While it improved the mitochondrial function of islets, the expression of anti-oxidative enzymes (SOD2, Trx1, Catalase), and survival rate. In vivo, engineering islet transplanted mice achieved euglycemia at earlier time. The TUNEL staining and insulin immunohistochemical (IHC) staining of the transplanted grafts showed that the islets transferred with CTRP9 had less apoptosis and more insulin positive cells than control ones. Conclusion: AAV mediated CTRP9 enhances the isolated murine islet anti-hypoxia ability and extended the islet graft survival time. And this study provided a clinic approach for islet homeo-transplantation. the National Key Research and Development Program (Grant No. 2019YFA0110703).